Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: The need for randomized trials

被引：16

作者：

Al-Aly, Z.

机构：

[1] St Louis Univ, St Louis Univ Hosp, Div Nephrol, St Louis, MO 63110 USA

[2] St Louis Vet Affairs Med Ctr, Div Nephrol, St Louis, MO USA

[3] St Louis Vet Affairs Clin Res & Epidemiol Ctr, St Louis, MO USA

来源：

KIDNEY INTERNATIONAL | 2007年 / 72卷 / 08期

关键词：

D O I：

10.1038/sj.ki.5002544

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolf et al. further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.

引用

收藏

页码：909 / 911

页数：4

相关论文

共 11 条

[1] Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].

Cheung, AK ;

Sarnak, MJ ;

Yan, GF ;

Dwyer, JT ;

Heyka, RJ ;

Rocco, MV ;

Teehan, BP ;

Levey, AS .

KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362

[2] Vitamin D [J].

Dusso, AS ;

Brown, AJ ;

Slatopolsky, E .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (01) :F8-F28

[3] Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients [J].

Kalantar-Zadeh, K. ;

Kuwae, N. ;

Regidor, D. L. ;

Kovesdy, C. P. ;

Kilpatrick, R. D. ;

Shinaberger, C. S. ;

McAllister, C. J. ;

Budoff, M. J. ;

Salusky, I. B. ;

Kopple, J. D. .

KIDNEY INTERNATIONAL, 2006, 70 (04) :771-780

[4] Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study [J].

Longenecker, JC ;

Coresh, J ;

Powe, NR ;

Levey, AS ;

Fink, NE ;

Martin, A ;

Klag, MJ .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07) :1918-1927

[5] Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study [J].

Melamed, M. L. ;

Eustace, J. A. ;

Plantinga, L. ;

Jaar, B. G. ;

Fink, N. E. ;

Coresh, J. ;

Klag, M. J. ;

Powe, N. R. .

KIDNEY INTERNATIONAL, 2006, 70 (02) :351-357

[6] The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease [J].

Muntner, P ;

Hamm, LL ;

Kusek, JW ;

Chen, J ;

Whelton, PK ;

He, J .

ANNALS OF INTERNAL MEDICINE, 2004, 140 (01) :9-17

[7] Lower risk for cardiovascular mortality in oral 1α-hydroxy vitamin D3 users in a haemodialysis population [J].

Shoji, T ;

Shinohara, K ;

Kimoto, E ;

Emoto, M ;

Tahara, H ;

Koyama, H ;

Inaba, M ;

Fukumoto, S ;

Ishimura, E ;

Miki, T ;

Tabata, T ;

Nishizawa, Y .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (01) :179-184

[8] Activated injectable vitamin D and hemodialysis survival:: A historical cohort study [J].

Teng, M ;

Wolf, M ;

Ofsthun, MN ;

Lazarus, JM ;

Hernán, MA ;

Camargo, CA ;

Thadhani, R .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1115-1125

[9] Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy [J].

Teng, M ;

Wolf, M ;

Lowrie, E ;

Ofsthun, N ;

Lazarus, JM ;

Thadhani, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (05) :446-456

[10] Mortality risk among hemodialysis patients receiving different vitamin D analogs [J].

Tentori, F. ;

Hunt, W. C. ;

Stidley, C. A. ;

Rohrscheib, M. R. ;

Bedrick, E. J. ;

Meyer, K. B. ;

Johnson, H. K. ;

Zager, P. G. .

KIDNEY INTERNATIONAL, 2006, 70 (10) :1858-1865